In HS skin lesions, WNK2 exhibits predominantly expression in non-immune cells and demonstrates a negative correlation with several pro-inflammatory cells, including Activated Mast cells and Neutrophils. This evidence concerns the gene WNK2 and histiocytic sarcoma.